Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma

NCT00083577 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
250
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Arkansas